News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Erman Akkus: Durable stable/partial response to atezo-beva in Hepatocellular Carcinoma
Photo from Erman Akkus/X
Aug 31, 2024, 17:17

Erman Akkus: Durable stable/partial response to atezo-beva in Hepatocellular Carcinoma

Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared on X:

“Durable stable/partial response to atezo-beva in Hepatocellular Carcinoma.

Significant proportion of HCC tumors become ghost tumors (radiologically persistent without viable tumor cells)

Durable: PR/SD >6 mo
IMbrave150
•CR, PR, SD: 8.9%, 22.1%, 44.2%
•77.8% of PRs and 28.5% SDs were durable
•Durable response -> better survival

Real-word, resection after atezo-beva
•pCR: 57.7% of PR tumors, 16.7% of SD tumors”

Erman Akkus

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab

Authors: Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas, Akihiko Soyama, Chang-Tsu Yuan, Tse-Ching Chen, Susumu Eguchi, Tomoharu Yoshizumi, Shinji Itoh, Noriaki Nakamura, Hisashi Kosaka, Masaki Kaibori, Takamichi Ishii, Etsuro Hatano, Chikara Ogawa, Atsushi Naganuma, Satoru Kakizaki, Chih-Hsien Cheng, Po-Ting Lin, Yung-YehSu, Chien-Huai Chuang, Li-Chun Lu, Chi-Jung Wu, Hung-Wei Wang, Kun-Ming Rau, Chih-Hung Hsu, Shi-Ming Lin, Yi-Hsiang Huang, Sairy Hernandez, Richard S. Finn, Masatoshi Kudo, Ann-Lii Cheng
Erman Akkus

Source: Erman Akkus/X

For more posts by Erman Akkus, visit oncodaily.com
AkihikoSoyama Alan Nicholas Ann-Lii Cheng Atsushi Naganuma cancer Chang-Tsu Yuan Chi-Jung Wu Chien-Huai Chuang Chih-Hsien Cheng Chih-Hung Hsu Chikara Ogawa Erman Akkus Etsuro Hatano Hepatocellular carcinoma (HCC) Hisashi Kosaka Hung-Wei Wang Kun-Ming Rau Li-Chun Lu Masaki Kaibori Masatoshi Kudo NoriakiNakamura OncoDaily Oncology Po-Ting Lin Richard S. Finn Sairy Hernandez Satoru Kakizaki Shi-Ming Lin Shinji Itoh SusumuEguchi Takamichi Ishii Tomoharu Yoshizumi Tse-Ching Chen Tsung-Hao Liu Yi-Hsiang Huang Ying-Chun Shen Yung-YehSu
Special Coverage
Blog
Nov 19, 2024, 10:22
Ilana Schlam: Updated treatment algorithms for Breast Cancer include adjuvant Ribociclib and Inavolisib
Insight
Nov 19, 2024, 10:18
Anita McGrath’s Advocacy Journey in Lung Cancer - IASLC
Blog
Nov 19, 2024, 10:10
The AACR is accepting submissions for the 2025 June L. Biedler Prize for Cancer Journalism
Blog
Nov 19, 2024, 10:05
NCCN in the 4th 2024 CCHIO
Blog
Nov 19, 2024, 09:59
Emad Shash: Another milestone in our journey of providing world-class cancer care in Upper Egypt
Blog
Nov 19, 2024, 09:53
Tackling Cancer Inequalities in North East London Cancer Alliance
Blog
Nov 19, 2024, 09:44
Association of Limited Health Literacy Among Older Adults With Cancer
Blog
Nov 19, 2024, 09:40
Runcie Chidebe: Excited to receive the 2024 James McKenny Award from AGHE
Blog
Nov 19, 2024, 09:36
Helena Yu on why lung cancer is more common in women than men in the 35-to-54 age group - MSKCC
Blog
Nov 19, 2024, 09:33
Abstract Submission for the 2025 edition of Drugging and Regulating the MAP Kinase Pathway - EACR
Opinion
Nov 19, 2024, 09:28
Reimagining Data Storage Through DNA Epigenetics - The Babak Lab
Blog
Nov 19, 2024, 09:22
Hospitals and Health Systems with Great Oncology Programs 2024 by Becker's Hospital Review